Blurry Eyes; Chills; hive spot is basically gone but there is a little discoloration; developed a "great big huge red dark pink like oval hive"; hive  was sore, itchy, and was hurting around the injection site; little rash spots around injection site; wiped out from the "residual hangover type of pain"; wiped out from the "residual hangover type of pain"; aches and pain that "hit with a vengeance"; soreness at the injection site; itching near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches and pain that "hit with a vengeance"), URTICARIA (developed a "great big huge red dark pink like oval hive"), HANGOVER (wiped out from the "residual hangover type of pain"), VACCINATION SITE DISCOLOURATION (hive spot is basically gone but there is a little discoloration) and FATIGUE (wiped out from the "residual hangover type of pain") in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tinnitus, Ulcerative colitis and Surgery (ileostomy surgery 10 years ago). Previously administered products included for Flu: Flu vaccine in 1989. Past adverse reactions to the above products included No adverse event with Flu vaccine. Concurrent medical conditions included Chronic pain, Fibromyalgia, Arthritis, Mitral valve prolapse, Supraventricular tachycardia (intermittent supraventricular tachycardia), Hypothyroidism, Burning mouth syndrome, Raynaud's disease (mild Raynaud's disease), Rosacea, Sjogren's syndrome, Sulfonamide allergy (severe rash and itching), Iodine contrast media allergy, Allergy to antibiotic (cleocin), Drug allergy (Clonazepam and Elavil (rapid heart)), Drug allergy (Allegra (cardiac reaction/severe chest pains),), Drug allergy (Inderal and Lopressor), Drug allergy (codeine, Ultram, prednisone, Darvocet, and Tylenol) and Drug allergy (prednisone (severe rash and itching)). Concomitant products included ATENOLOL, LEVOTHYROXINE, ALPRAZOLAM, VITAMIN D3, LORATADINE and NYSTATIN for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching near the injection site) and VACCINATION SITE PAIN (soreness at the injection site). On 16-Jan-2021, the patient experienced PAIN (aches and pain that "hit with a vengeance"), HANGOVER (wiped out from the "residual hangover type of pain") and FATIGUE (wiped out from the "residual hangover type of pain"). On 17-Jan-2021, the patient experienced URTICARIA (developed a "great big huge red dark pink like oval hive"), VACCINATION SITE URTICARIA (hive  was sore, itchy, and was hurting around the injection site) and VACCINATION SITE RASH (little rash spots around injection site). On 22-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (hive spot is basically gone but there is a little discoloration). On an unknown date, the patient experienced CHILLS (Chills) and VISION BLURRED (Blurry Eyes). The patient was treated with CORTISONE (topical) for Hives, at an unspecified dose and frequency. On 24-Jan-2021, URTICARIA (developed a "great big huge red dark pink like oval hive") and VACCINATION SITE URTICARIA (hive  was sore, itchy, and was hurting around the injection site) had resolved. At the time of the report, PAIN (aches and pain that "hit with a vengeance") had resolved and HANGOVER (wiped out from the "residual hangover type of pain"), VACCINATION SITE DISCOLOURATION (hive spot is basically gone but there is a little discoloration), FATIGUE (wiped out from the "residual hangover type of pain"), VACCINATION SITE PRURITUS (itching near the injection site), VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE RASH (little rash spots around injection site), CHILLS (Chills) and VISION BLURRED (Blurry Eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient medical historical conditions also included back problems, stomach, issues and low end normal vitamin D levels. Patient reported that she took Loratadine and Alprazolam 2 hours before vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: This non-significant follow-up was received on 16-APR-2021 which updated reporter's email address. On 11-Jun-2021: